ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
Study sponsor: Abivax S.A. · ABVX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2018-07-25Actual
Enrollment · participants32Actual
Source updated2024-06-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.